Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-30T20:04:22.491Z Has data issue: false hasContentIssue false
  • English
  • Français

Substrate specificity of the neutral sphingomyelinase from Trypanosoma brucei

Published online by Cambridge University Press:  05 November 2018

Emily A. Dickie ,
Simon A. Young  and
Terry K. Smith Open the ORCID record for Terry K. Smith [Opens in a new window]
Emily A. Dickie
Affiliation:
Biomedical Sciences Research Complex, Schools of Biology and Chemistry, University of St Andrews, Fife, KY16 9ST, UK
Simon A. Young
Affiliation:
Biomedical Sciences Research Complex, Schools of Biology and Chemistry, University of St Andrews, Fife, KY16 9ST, UK
Terry K. Smith*
Affiliation:
Biomedical Sciences Research Complex, Schools of Biology and Chemistry, University of St Andrews, Fife, KY16 9ST, UK
*
Author for correspondence: Terry K. Smith, E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

The kinetoplastid parasite Trypanosoma brucei causes African trypanosomiasis in both humans and animals. Infections place a significant health and economic burden on developing nations in sub-Saharan Africa, but few effective anti-parasitic treatments are currently available. Hence, there is an urgent need to identify new leads for drug development. The T. brucei neutral sphingomyelinase (TbnSMase) was previously established as essential to parasite survival, consequently being identified as a potential drug target. This enzyme may catalyse the single route to sphingolipid catabolism outside the T. brucei lysosome. To obtain new insight into parasite sphingolipid catabolism, the substrate specificity of TbnSMase was investigated using electrospray ionization tandem mass spectrometry (ESI-MS/MS). Recombinant TbnSMase was shown to degrade sphingomyelin, inositol-phosphoceramide and ethanolamine-phosphoceramide sphingolipid substrates, consistent with the sphingolipid complement of the parasites. TbnSMase also catabolized ceramide-1-phosphate, but was inactive towards sphingosine-1-phosphate. The broad-range specificity of this enzyme towards sphingolipid species is a unique feature of TbnSMase. Additionally, ESI-MS/MS analysis revealed previously uncharacterized activity towards lyso-phosphatidylcholine despite the enzyme's inability to degrade phosphatidylcholine. Collectively, these data underline the enzyme's importance in choline homoeostasis and the turnover of sphingolipids in T. brucei.

Keywords

Activity assaycholineenzymelipid catabolismlipid extractionmass spectrometrysphingolipid
Type
Research Article
Information
Parasitology , Volume 146 , Issue 5 , April 2019 , pp. 604 - 616
Check for updates
Copyright
Copyright © Cambridge University Press 2018 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

*

Current address: Wellcome Trust Centre for Molecular Parasitology, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, G12 8TA, UK.

References

Ago, H, Oda, M, Takahashi, M, Tsuge, H, Ochi, S, Katunuma, N, Miyano, M and Sakurai, J (2006) Structural basis of the sphingomyelin phosphodiesterase activity in neutral sphingomyelinase from Bacillus cereus. Journal of Biological Chemistry 281, 16157–16167.Google Scholar
Avanti Polar Lipids (2018) 860062 Brain SM, Sphingomyelin (Brain, Porcine). Retrieved from Avanti Polar Lipids website. Available at https://avantilipids.com/product/860062 (Accessed 24 January 2018).Google Scholar
Bligh, EG and Dyer, WJ (1959) A rapid method of total lipid extraction and purification. Canadian Journal of Biochemsitry and Physiology 37, 911–917.Google Scholar
Bowes, E, Samad, H, Jiang, P, Weaver, B and Mellors, A (1993) The acquisition of lysophosphatidylcholine by African trypanosomes. Journal of Biological Chemistry 268, 13885–13892.Google Scholar
Brun, R and Schönenberger, M (1979) Cultivation and in vitro cloning or procyclic culture forms of Trypanosoma brucei in a semi-defined medium. Short communication. Acta Tropica 36, 289–292.Google Scholar
De Lederkremer, RM, Agusti, R and Docampo, R (2011) Inositolphosphoceramide metabolism in Trypanosoma cruzi as compared with other trypanosomatids. Journal of Eukaryotic Microbiology 58, 79–87.Google Scholar
Denny, PW, Goulding, D, Ferguson, MAJ and Smith, DF (2004) Sphingolipid-free Leishmania are defective in membrane trafficking, differentiation and infectivity. Molecular Microbiology 52, 313–327.Google Scholar
Denny, PW, Shams-Eldin, H, Price, HP, Smith, DF and Schwartz, RT (2006) The protozoan inositol phosporylceramide synthase: a novel drug target which defines a new class of sphingolipid synthase. Journal of Biological Chemistry 281, 28200–28209.Google Scholar
Fridberg, A, Olson, CL, Nakayasu, ES, Tyler, KM, Almeida, IC and Engman, DM (2008) Sphingolipid synthesis is necessary for kinetoplast segregation and cytokinesis in Trypanosoma brucei. Journal of Cell Science 121, 522–535.Google Scholar
Gerold, P and Schwarz, RT (2001) Biosynthesis of glycosphingolipids de-novo by the human malaria parasite Plasmodium falciparum. Molecular and Biochemical Parasitology 112, 29–37.Google Scholar
Goren, MA, Fox, BG and Bangs, JD (2011) Amino acid determinants of substrate selectivity in the Trypanosoma brucei sphingolipid synthase family. Biochemistry 50, 8853–8861.Google Scholar
Guan, XL and Mäser, P (2017) Comparative sphingolipidomics of disease-causing trypanosomatids reveal unique lifecycle- and taxonomy-specific lipid chemistries. Scientific Reports 7, 1–13.Google Scholar
Hanada, K, Palacpac, NMQ, Magistrado, PA, Kurokawa, K, Rai, G, Sakata, D, Hara, T, Horii, T, Nishijima, M and Mitamura, T (2002) Plasmodium falciparum phospholipase C hydrolyzing sphingomyelin and lysocholinephospholipids is a possible target for malaria chemotherapy. Journal of Experimental Medicine 195, 23–34.Google Scholar
Jenkins, RW, Canals, D and Hannun, YA (2009) Roles and regulation of secretory and lysosomal acid sphingomyelinase. Cellular Signalling 21, 836–846.Google Scholar
Jenkins, RW, Idkowiak-Baldys, J, Simbari, F, Canals, D, Roddy, P, Riner, CD, Clarke, CJ and Hannun, YA (2011) A novel mechanism of lysosomal acid sphingomyelinase maturation: requirement for carboxyl-terminal proteolytic processing. Journal of Biological Chemistry 286, 3777–3788.Google Scholar
Kolter, T and Sandhoff, K (1999) Sphingolipids-their metabolic pathways and the pathobiochemistry of neurodegenerative diseases. Angewandte Chemie (International Edition in English) 38, 1532–1568.Google Scholar
Macêdo, JP, Schmidt, RS, Mäser, P, Rentsch, D, Vial, HJ, Sigel, E and Bütikofer, P (2013) Characterization of choline uptake in Trypanosoma brucei procyclic and bloodstream forms. Molecular and Biochemical Parasitology 190, 16–22.Google Scholar
McConville, MJ and Naderer, T (2011) Metabolic pathways required for the intracellular survival of Leishmania. Annual Review of Microbiology 65, 543–561.Google Scholar
Mina, JGM and Denny, PW (2017) Everybody needs sphingolipids, right! Mining for new drug targets in protozoan sphingolipid biosynthesis. Parasitology 145, 1341–147.Google Scholar
Mina, JG, Pan, S-Y, Wansadhipathi, NK, Bruce, CR, Shams-Eldin, H, Schwarz, RT, Steel, PG and Denny, PW (2009) The Trypanosoma brucei sphingolipid synthase, an essential enzyme and drug target. Molecular and Biochemical Parasitology 168, 16–23.Google Scholar
Mugnier, MR, Stebbins, CE and Papavasiliou, FN (2016) Masters of disguise: antigenic variation and the VSG coat in Trypanosoma brucei. PLoS Pathogens 12, 1–6.Google Scholar
Openshaw, AEA, Race, PR, Monzó, HJ, Vázquez-Boland, J-A and Banfield, MJ (2005) Crystal structure of SmcL, a bacterial neutral sphingomyelinase C from Listeria. Journal of Biological Chemistry 280, 35011–7.Google Scholar
Richmond, GS and Smith, TK (2007 a) A novel phospholipase from Trypanosoma brucei. Molecular Microbiology 63, 1078–1095.Google Scholar
Richmond, GS and Smith, TK (2007 b) The role and characterization of phospholipase A1 in mediating lysophosphatidylcholine synthesis in Trypanosoma brucei. Biochemical Journal 405, 319–329.Google Scholar
Richmond, GS, Gibellini, F, Young, SA, Major, L, Denton, H, Lilley, A and Smith, TK (2010) Lipidomic analysis of bloodstream and procyclic form Trypanosoma brucei. Parasitology 137, 1357–1392.Google Scholar
Serricchio, M and Bütikofer, P (2011) Trypanosoma brucei: a model micro-organism to study eukaryotic phospholipid biosynthesis. FEBS Journal 278, 1035–1046.Google Scholar
Sevova, ES, Goren, MA, Schwartz, KJ, Hsu, F-F, Turk, J, Fox, BG and Bangs, JD (2010) Cell-free synthesis and functional characterization of sphingolipid synthases from parasitic trypanosomatid protozoa. Journal of Biological Chemistry 285, 20580–7.Google Scholar
Shaw, APM, Cecchi, G, Wint, GRW, Mattioli, RC and Robinson, TP (2014) Mapping the economic benefits to livestock keepers from intervening against bovine trypanosomosis in Eastern Africa. Preventive Veterinary Medicine 113, 197–210.Google Scholar
Smith, TK and Bütikofer, P (2010) Lipid metabolism in Trypanosoma brucei. Molecular and Biochemical Parasitology 172, 66–79.Google Scholar
Sutterwala, SS, Hsu, F-F, Sevova, ES, Schwartz, KJ, Zhang, K, Key, P, Turk, J, Beverley, SM and Bangs, JD (2008) Developmentally regulated sphingolipid synthesis in African trypanosomes. Molecular Microbiology 70, 281–296.Google Scholar
Tidhar, R and Futerman, AH (2013) The complexity of sphingolipid biosynthesis in the endoplasmic reticulum. Biochimica et Biophysica Acta 1833, 2511–2518.Google Scholar
Uemura, A, Watarai, S, Kushi, Y, Kasama, T, Ohnishi, Y and Kodama, H (2006) Analysis of neutral glycosphingolipids from Trypanosoma brucei. Veterinary Parasitology 140, 264–272.Google Scholar
Wirtz, E, Leal, S, Ochatt, C and Cross, GA (1999) A tightly regulated inducible expression system for conditional gene knock-outs and dominant-negative genetics in Trypanosoma brucei. Molecular and Biochemical Parasitology 99, 89–101.Google Scholar
World Health Organization (2017 a) Trypansomiasis, human African (sleeping sickness). Retrieved from the World Health Organization website. Available at http://www.who.int/mediacentre/factsheets/fs259/en/ (Accessed 25 August 2017).Google Scholar
World Health Organization (2017 b) Integrating Neglected Tropical Diseases Into Global Health and Development: Fourth WHO Report on Neglected Tropical Diseases. Geneva, Switzerland: World Health Organization.Google Scholar
Xu, W, Xin, L, Soong, L and Zhang, K (2011) Sphingolipid degradation by Leishmania major is required for its resistance to acidic pH in the mammalian host. Infection and Immunity 79, 3377–3387.Google Scholar
Young, SA and Smith, TK (2010) The essential neutral sphingomyelinase is involved in the trafficking of the variant surface glycoprotein in the bloodstream form of Trypanosoma brucei. Molecular Microbiology 76, 1461–1482.Google Scholar
Zhang, K, Pompey, JM, Hsu, F-F, Key, P, Bandhuvula, P, Saba, JD, Turk, J and Beverley, SM (2007) Redirection of sphingolipid metabolism toward de novo synthesis of ethanolamine in Leishmania. EMBO Journal 26, 1094–1104.Google Scholar
Zhang, O, Wilson, MC, Xu, W, Hsu, F-F, Turk, J, Kuhlmann, FM, Wang, Y, Soong, L, Key, P, Beverley, SM and Zhang, K (2009) Degradation of host sphingomyelin is essential for Leishmania virulence. PLoS Pathogens 5, e1000692.Google Scholar
Zhang, O, Xu, W, Balakrishna Pillai, A and Zhang, K (2012) Developmentally regulated sphingolipid degradation in Leishmania major. PLoS One 7, e31059.Google Scholar
Supplementary material: PDF

Dickie et al. supplementary material

Figures S1-S9

Download Dickie et al. supplementary material(PDF)
PDF 748.5 KB